PharmAthene's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Year End 2013 PharmAthene Incorporated Earnings Conference Call.
PHARMATHENE, INC - 10-K - Management's Discussion and Analysis of...
The following discussion should be read in conjunction with our consolidated financial statements, which present our results of operations for the years ended and 2012, contained elsewhere in this Annual Report on Form 10-K.
PharmAthene Reports Year-End 2013 Financial And Operational Results
"We have a clear path forward based on comments from the U.S. Food and Drug Administration , which includes manufacturing a new clinical lot for use in the proposed study.
RDInvesting Provides Investors with Free In-Depth Equity Reports on...
Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events.
PharmAthene to Host Year-End 2013 Conference Call and Webcast on Tuesday, March 11, 2014
The call is scheduled to begin at is 866-318-8616. The dial-in number for international callers is 617-399-5135.
Recently released market study: PharmAthene, Inc. (PIP) -...
The company develops and commercializes medical counter measures to biological and chemical weapons.